Physician profile
Julie A Meyer
NPI 1265476360
$1,315.30
in general payments reported to CMS, 2019-2025
24 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2021: $70.43 · 2022: $302 · 2023: $360 · 2024: $272 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $829.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $282.24 | 2021-2025 | |
| Astellas Pharma US INC | $114.28 | 2023-2025 | Veozah |
| Pfizer INC. | $109.86 | 2021-2025 | |
| Medtronic, INC. | $97.93 | 2022-2024 | V-Loc 180, Ligasure |
| Organon LLC | $79.00 | 2023-2024 | Nexplanon |
| Intuitive Surgical, INC. | $68.43 | 2019 | |
| Exeltis, USA INC. | $68.42 | 2023-2025 | Slynd |
| Myriad Women'S Health, INC. | $66.89 | 2023 | |
| Axonics, INC. | $49.00 | 2022-2023 | Axonics |
| Conmed Corporation | $45.45 | 2019 | |
| Sage Therapeutics, LLC | $45.11 | 2024-2025 | Zurzuvae |
| Exact Sciences Corporation | $42.22 | 2023-2024 | Cologuard Collection Kit |
| Myovant Sciences INC. | $33.51 | 2022 | |
| Daiichi Sankyo INC. | $28.87 | 2024 | Injectafer |
| Pharmacosmos Therapeutics INC. | $23.48 | 2024 | Monoferric |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $22.68 | 2025 | Pico 14 |
| Hologic Sales and Service, LLC | $20.72 | 2022 | |
| Solventum Corporation | $20.16 | 2025 | Prevena |
| Merck Sharp & Dohme LLC | $18.30 | 2023 | Gardasil 9, Recombivax Hb |
| Sumitomo Pharma America, INC. | $17.62 | 2023 | Myfembree |
| Novo Nordisk INC | $17.39 | 2021 | |
| Ethicon US, LLC | $14.97 | 2022 | |
| Minerva Surgical, INC | $14.50 | 2021 | |
| Lilly USA, LLC | $14.27 | 2025 | Zepbound, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.